申请人:Huang Zilin
公开号:US20130210818A1
公开(公告)日:2013-08-15
New substituted heterocyclic compounds, compositions containing them, and methods of using them for the inhibition of Raf kinase activity are provided. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.
提供了新的替代杂环化合物,含有它们的组合物,以及使用它们抑制Raf激酶活性的方法。这些新化合物和组合物可以单独使用,也可以与至少一种额外的药物联合使用,用于治疗由Raf激酶介导的疾病,如癌症。